AlloMap^®

AlloMap^® testing is intended to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (ACR) at the time of testing in conjunction with standard clinical assessment.

Product Information

XDx Laboratory Services Guide for AlloMap^® HTx Molecular Expression Testing

• Material Safety Data Sheet (CPT Tubes)
• Material Safety Data Sheet (Dry Ice)
• Material Safety Data Sheet (PBS)
• Material Safety Data Sheet (LyseDx)

AlloMap^® HTx Molecular Expression Testing Bridging Letter (pre and post FDA clearance product information)